EpiPredict

The mission of EpiPredict is to train a multidisciplinary cohort of young researchers in a new approach to fully exploit the epigenetics of complex diseases. The 12 early-stage researchers (ESRs) will focus on a narrowly defined case, Tamoxifen-induced resistance in Estrogen Receptor positive (ER+) breast cancer, considering five interacting resistance pathways. Read more...

We warmly invite you to the Systems Epigenetics Conference, Amsterdam, 27-30 November 2018!

Please visit our news page for the latest announcements and press or our Facebook or Twitter pages!

News

Every scientist should meet a patient, EpiPredict blog published in Medium

2018-02-13

Insides from Breast Cancer researcher Dr Luca Magnani from Imperial College London, UK. EpiPredict PhD fellow Simone Borgoni, from the German Cancer Research Centre, DKFZ, DE, interviewed Dr Magnani and wrote a blog for Medium.

Read more


Announcement conference Systems Epigenetics: Towards Precision Cancer Medicine, Amsterdam, NL, 27-30 November 2018

2018-02-09

We are honored to announce the conference ‘Systems Epigenetics: Towards Precision Cancer Medicine’ that we organize in Amsterdam, the Netherlands on 27-30 November 2018.

Read more


Why scientists investigate 'epigenetics' in their quest to defeat breast cancer, a video by EpiPredict researchers

2018-01-29

In this video Daniel Vilar Jorge explains why we study epigenetics in the resistance to endocrine therapy in breast cancer. It was first publicly presented during our first Science Café organized at DKFZ, Heidelberg, 2017.

Read more


Events

ma26nov

Systems Epigenetics Conference 2018

KIT, Amsterdam - NL, 27-30 November 2018

We are honored to announce the conference ‘Systems Epigenetics: Towards Precision Cancer Medicine’ that we organize in Amsterdam, the Netherlands on 27-30 November 2018.

Visit the #SysEpi2018 Conference website!

 


vr15dec

EpiPredict science cafe

Imperial College London - UK, 14 December 2017

Second EpiPredict Science Café at Maggie's Centre, in front of Charing Cross Hospital

Imperial College London, UK, Thursday 14, December, 2017

At this Imperial Science Cafe (ex-) patients and their representatives were invited to talk about epigenetic influences on breast cancer therapy resistance.

To view the flyer, click here.


do26jan

Epigenetics, everything you always wanted to know

DKFZ - Heidelberg, 26 January 2017

13:30-17:00

Epigenetics, everything you always wanted to know

DKFZ, Heidelberg, DE, Thursday 26 January, 2017, 13:30-17:00

Keynote speaker: Prof. Henk Stunnenberg, Radboud University Medical Centre, NL

Science café: Applying epigenetics in breast cancer treatment